---
id: esh-hypertension-2024
title: "2024 ESH Clinical Practice Guidelines for the Management of Arterial Hypertension"
short_title: "ESH Hypertension 2024"

organization: European Society of Hypertension
collaborators: null
country: Global (Europe-led)
url: https://www.eshonline.org/guidelines/
doi: null
pmid: null
open_access: true

specialty: cardiology
guideline_type: clinical-practice
evidence_system: ESH
conditions:
  - hypertension
  - arterial hypertension
  - resistant hypertension
tags:
  - blood pressure targets
  - antihypertensives
  - ABPM
  - CVD risk
  - home BP

publication_date: 2024-06-01
previous_version_date: 2023-06-01
status: current
supersedes: null
superseded_by: null

pdf_path: null
has_pdf: false
last_reviewed: 2025-12-23
---

## Scope
Concise 2024 ESH guideline summarizing key recommendations from the comprehensive 2023 ESH guidelines for the management of arterial hypertension.

## Key Recommendations

### Classification
- **Optimal**: <120/<80 mmHg.
- **Normal**: 120-129/80-84 mmHg.
- **High-Normal**: 130-139/85-89 mmHg.
- **Grade 1 Hypertension**: 140-159/90-99 mmHg.
- **Grade 2 Hypertension**: 160-179/100-109 mmHg.
- **Grade 3 Hypertension**: ≥180/≥110 mmHg.

### Measurement
- **Out-of-Office BP**: Confirms diagnosis and guides therapy. Use home blood pressure monitoring (HBPM) or 24-hour ambulatory blood pressure monitoring (ABPM) to identify white-coat and masked hypertension.

### Treatment Thresholds
- **General Adults**: Start pharmacotherapy for Grade 1 hypertension (≥140/90 mmHg) if lifestyle modifications fail after 3-6 months.
- **High-Risk Patients**: Consider initiating treatment at high-normal BP (130-139/85-89) for those with established CVD or very high CVD risk.

### Treatment Targets
- **General Target**: Aim for on-treatment SBP of 120-130 mmHg for most patients, provided it is well tolerated.
- **Older Adults (65-79)**: Target <140 mmHg; consider <130 if tolerated.
- **Older Adults (≥80)**: Target <150 mmHg; aim for <140 if fit.

### First-Line Drug Classes
- **ACE inhibitors or ARBs**.
- **Calcium Channel Blockers (dihydropyridines)**.
- **Thiazide/Thiazide-like Diuretics (e.g., chlorthalidone, indapamide)**.

### Treatment Strategy
- **Initial Combination Therapy**: Preferably as a **single-pill combination (SPC)**, is recommended for most patients. Common two-drug combinations: RAS blocker + CCB or RAS blocker + diuretic.
- **Three-Drug Combination**: For uncontrolled BP, a three-drug SPC (RAS blocker + CCB + diuretic) is recommended.

### Resistant Hypertension
- **Add-on**: Spironolactone (MR antagonist) is the recommended fourth-line agent.
